Logo image of NGVT

INGEVITY CORP (NGVT) Stock Fundamental Analysis

NYSE:NGVT - New York Stock Exchange, Inc. - US45688C1071 - Common Stock - Currency: USD

46.4  +0.64 (+1.4%)

After market: 46.4 0 (0%)

Fundamental Rating

4

Overall NGVT gets a fundamental rating of 4 out of 10. We evaluated NGVT against 85 industry peers in the Chemicals industry. NGVT has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on NGVT.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year NGVT was profitable.
In the past year NGVT had a positive cash flow from operations.
In multiple years NGVT reported negative net income over the last 5 years.
In the past 5 years NGVT always reported a positive cash flow from operatings.
NGVT Yearly Net Income VS EBIT VS OCF VS FCFNGVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -17.21%, NGVT is doing worse than 80.00% of the companies in the same industry.
With a Return On Equity value of -150.81%, NGVT is not doing good in the industry: 92.94% of the companies in the same industry are doing better.
The Return On Invested Capital of NGVT (12.56%) is better than 92.94% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NGVT is above the industry average of 6.83%.
The last Return On Invested Capital (12.56%) for NGVT is above the 3 year average (10.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -17.21%
ROE -150.81%
ROIC 12.56%
ROA(3y)-4.58%
ROA(5y)-0.24%
ROE(3y)-63.66%
ROE(5y)-29.04%
ROIC(3y)10.65%
ROIC(5y)10.84%
NGVT Yearly ROA, ROE, ROICNGVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

NGVT has a better Operating Margin (21.09%) than 88.24% of its industry peers.
In the last couple of years the Operating Margin of NGVT has declined.
The Gross Margin of NGVT (34.69%) is better than 69.41% of its industry peers.
In the last couple of years the Gross Margin of NGVT has declined.
Industry RankSector Rank
OM 21.09%
PM (TTM) N/A
GM 34.69%
OM growth 3Y-6.17%
OM growth 5Y-4.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.27%
GM growth 5Y-2.81%
NGVT Yearly Profit, Operating, Gross MarginsNGVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NGVT is creating some value.
NGVT has more shares outstanding than it did 1 year ago.
NGVT has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, NGVT has a worse debt to assets ratio.
NGVT Yearly Shares OutstandingNGVT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NGVT Yearly Total Debt VS Total AssetsNGVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.22 indicates that NGVT is not a great score, but indicates only limited risk for bankruptcy at the moment.
NGVT's Altman-Z score of 2.22 is in line compared to the rest of the industry. NGVT outperforms 57.65% of its industry peers.
NGVT has a debt to FCF ratio of 14.65. This is a negative value and a sign of low solvency as NGVT would need 14.65 years to pay back of all of its debts.
The Debt to FCF ratio of NGVT (14.65) is comparable to the rest of the industry.
NGVT has a Debt/Equity ratio of 5.68. This is a high value indicating a heavy dependency on external financing.
NGVT's Debt to Equity ratio of 5.68 is on the low side compared to the rest of the industry. NGVT is outperformed by 91.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.68
Debt/FCF 14.65
Altman-Z 2.22
ROIC/WACC1.43
WACC8.79%
NGVT Yearly LT Debt VS Equity VS FCFNGVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

NGVT has a Current Ratio of 2.00. This indicates that NGVT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of NGVT (2.00) is comparable to the rest of the industry.
NGVT has a Quick Ratio of 1.08. This is a normal value and indicates that NGVT is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.08, NGVT perfoms like the industry average, outperforming 42.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.08
NGVT Yearly Current Assets VS Current LiabilitesNGVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

NGVT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.90%, which is quite impressive.
The Earnings Per Share has been decreasing by -6.12% on average over the past years.
The Revenue for NGVT has decreased by -17.64% in the past year. This is quite bad
Measured over the past years, NGVT shows a small growth in Revenue. The Revenue has been growing by 1.70% on average per year.
EPS 1Y (TTM)20.9%
EPS 3Y-11.81%
EPS 5Y-6.12%
EPS Q2Q%90.38%
Revenue 1Y (TTM)-17.64%
Revenue growth 3Y0.36%
Revenue growth 5Y1.7%
Sales Q2Q%-16.5%

3.2 Future

Based on estimates for the next years, NGVT will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.18% on average per year.
Based on estimates for the next years, NGVT will show a small growth in Revenue. The Revenue will grow by 1.23% on average per year.
EPS Next Y21.23%
EPS Next 2Y18.67%
EPS Next 3Y17.18%
EPS Next 5YN/A
Revenue Next Year-5.89%
Revenue Next 2Y-0.73%
Revenue Next 3Y1.23%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NGVT Yearly Revenue VS EstimatesNGVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
NGVT Yearly EPS VS EstimatesNGVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.46, which indicates a very decent valuation of NGVT.
NGVT's Price/Earnings ratio is rather cheap when compared to the industry. NGVT is cheaper than 85.88% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.04. NGVT is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 9.20, which indicates a very decent valuation of NGVT.
NGVT's Price/Forward Earnings ratio is rather cheap when compared to the industry. NGVT is cheaper than 85.88% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 37.64. NGVT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.46
Fwd PE 9.2
NGVT Price Earnings VS Forward Price EarningsNGVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NGVT is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
74.12% of the companies in the same industry are more expensive than NGVT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.79
EV/EBITDA 7.7
NGVT Per share dataNGVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NGVT's earnings are expected to grow with 17.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.54
PEG (5Y)N/A
EPS Next 2Y18.67%
EPS Next 3Y17.18%

More info and screens

0

5. Dividend

5.1 Amount

NGVT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INGEVITY CORP

NYSE:NGVT (7/25/2025, 8:10:47 PM)

After market: 46.4 0 (0%)

46.4

+0.64 (+1.4%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners103.19%
Inst Owner Change-0.08%
Ins Owners1.03%
Ins Owner Change24.4%
Market Cap1.69B
Analysts82
Price Target52.79 (13.77%)
Short Float %3.3%
Short Ratio4.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)117.25%
Min EPS beat(2)31.61%
Max EPS beat(2)202.89%
EPS beat(4)3
Avg EPS beat(4)62.07%
Min EPS beat(4)-6.05%
Max EPS beat(4)202.89%
EPS beat(8)6
Avg EPS beat(8)64.28%
EPS beat(12)8
Avg EPS beat(12)41.57%
EPS beat(16)11
Avg EPS beat(16)35.74%
Revenue beat(2)0
Avg Revenue beat(2)-4.11%
Min Revenue beat(2)-5.75%
Max Revenue beat(2)-2.47%
Revenue beat(4)0
Avg Revenue beat(4)-4.53%
Min Revenue beat(4)-6.04%
Max Revenue beat(4)-2.47%
Revenue beat(8)2
Avg Revenue beat(8)-1.58%
Revenue beat(12)4
Avg Revenue beat(12)-0.92%
Revenue beat(16)8
Avg Revenue beat(16)1.42%
PT rev (1m)0%
PT rev (3m)-11.54%
EPS NQ rev (1m)-0.64%
EPS NQ rev (3m)-9.18%
EPS NY rev (1m)0.12%
EPS NY rev (3m)-4.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)-2.72%
Valuation
Industry RankSector Rank
PE 11.46
Fwd PE 9.2
P/S 1.25
P/FCF 17.79
P/OCF 10.19
P/B 7.21
P/tB N/A
EV/EBITDA 7.7
EPS(TTM)4.05
EY8.73%
EPS(NY)5.04
Fwd EY10.86%
FCF(TTM)2.61
FCFY5.62%
OCF(TTM)4.56
OCFY9.82%
SpS37.04
BVpS6.43
TBVpS-6.11
PEG (NY)0.54
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.21%
ROE -150.81%
ROCE 15.9%
ROIC 12.56%
ROICexc 13.08%
ROICexgc 17.82%
OM 21.09%
PM (TTM) N/A
GM 34.69%
FCFM 7.04%
ROA(3y)-4.58%
ROA(5y)-0.24%
ROE(3y)-63.66%
ROE(5y)-29.04%
ROIC(3y)10.65%
ROIC(5y)10.84%
ROICexc(3y)11.07%
ROICexc(5y)11.72%
ROICexgc(3y)17.77%
ROICexgc(5y)19.74%
ROCE(3y)13.49%
ROCE(5y)13.72%
ROICexcg growth 3Y-8.19%
ROICexcg growth 5Y-5.86%
ROICexc growth 3Y-1.67%
ROICexc growth 5Y-0.8%
OM growth 3Y-6.17%
OM growth 5Y-4.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.27%
GM growth 5Y-2.81%
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 5.68
Debt/FCF 14.65
Debt/EBITDA 3.43
Cap/Depr 68.53%
Cap/Sales 5.26%
Interest Coverage 3.43
Cash Conversion 42.77%
Profit Quality N/A
Current Ratio 2
Quick Ratio 1.08
Altman-Z 2.22
F-Score5
WACC8.79%
ROIC/WACC1.43
Cap/Depr(3y)97.35%
Cap/Depr(5y)93.69%
Cap/Sales(3y)6.85%
Cap/Sales(5y)6.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.9%
EPS 3Y-11.81%
EPS 5Y-6.12%
EPS Q2Q%90.38%
EPS Next Y21.23%
EPS Next 2Y18.67%
EPS Next 3Y17.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.64%
Revenue growth 3Y0.36%
Revenue growth 5Y1.7%
Sales Q2Q%-16.5%
Revenue Next Year-5.89%
Revenue Next 2Y-0.73%
Revenue Next 3Y1.23%
Revenue Next 5YN/A
EBIT growth 1Y24.1%
EBIT growth 3Y-5.83%
EBIT growth 5Y-2.78%
EBIT Next Year58.8%
EBIT Next 3Y22.73%
EBIT Next 5YN/A
FCF growth 1Y-38.13%
FCF growth 3Y-35.4%
FCF growth 5Y-20.53%
OCF growth 1Y-43.5%
OCF growth 3Y-24%
OCF growth 5Y-14.15%